Dianthus Therapeutics, Inc.

Historical 13F Holders

Symbol
DNTH
CUSIP
252828108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 252828108 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.0% 11/5/2025
Event 9/30/2025
T. Rowe Price Investment Management, Inc. 13G/A 10.5% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 6.4% 7/28/2026
Event 6/30/2026
Wellington Management Group LLP 13G
5.9% 8/13/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.1% 10/30/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (11)
Fairmount Funds Management LLC 13D/A
4.9% 11/25/2025
Event 11/21/2025
Avidity Partners Management LP 13D/A
4.9% 11/19/2025
Event 11/17/2025
RA Capital Management, L.P. 13G/A
4.8% 5/15/2026
Event 3/31/2026
TCG Crossover GP II, LLC 13G/A
4.7% 5/15/2025
Event 3/31/2025
Octagon Capital Advisors LP 13G/A
3.6% 5/14/2026
Event 3/31/2026
Sirenia Capital Management LP 13G/A
3.1% 8/14/2026
Event 6/30/2026
BCLS Fund III Investments, LP 13G/A 3.1% 11/14/2025
Event 9/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
3.1% 8/14/2025
Event 6/30/2025
Vestal Point Capital, LP 13G/A
3.0% 11/14/2025
Event 9/30/2025
Point72 Asset Management, L.P. 13G/A
1.2% 5/15/2026
Event 3/31/2026
Deep Track Capital, LP 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 279 67.4 M $5.94B
2026 Q2 275 65.8 M $6.40B
2026 Q1 243 64.3 M $5.36B
2025 Q4 166 49.1 M $2.02B
2025 Q3 141 46.8 M $1.84B
2025 Q2 105 39.1 M $729M
2025 Q1 101 37.7 M $685M
2024 Q4 97 35.1 M $766M
2024 Q3 92 31.4 M $858M
2024 Q2 75 29.7 M $769M
2024 Q1 77 26.1 M $782M
2023 Q4 40 10.3 M $107M
2023 Q3 31 10.1 M $136M